Analysis of gene expression profiles in the offspring of rats following maternal exposure to xenoestrogens

Reproductive Toxicology

Volumn 23, Issue 1, 2007, Pages 42-54

  Dang, Vu Hoang ^a   Choi, Kyung Chul ^b   Hyun, Sang Hwan ^a   Jeung, Eui Bae ^a  

^a Research Institute of Veterinary Medicine   (South Korea)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

cDNA microarray technology; Endocrine disruptors; Estrogenicity; Uterus

Indexed keywords

4 TERT OCTYLPHENOL; CALBINDIN; CALBINDIN 3; COMPLEMENT COMPONENT C3; COMPLEMENTARY DNA; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; LYMPHOCYTE SPECIFIC 1 PROTEIN; PROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR IIA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORRELATION ANALYSIS; DNA MICROARRAY; ENVIRONMENTAL EXPOSURE; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GESTATIONAL AGE; LACTATION; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PROGENY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UTERUS; VALIDATION STUDY;

ANIMALS; ANIMALS, NEWBORN; DIETHYLSTILBESTROL; ESTROGEN ANTAGONISTS; ESTROGENS, NON-STEROIDAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; MATERNAL EXPOSURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOLS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURFACE-ACTIVE AGENTS; UTERUS;

RATTUS;

EID: 33845899670     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2006.08.010     Document Type: Article

References (59)

1. Korach K.S., Chae K., Gibson M., and Curtis S. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness. Steroids 56 (1991) 263-270
2. Gray Jr. L.E., Kelce W.R., Wiese T., Tyl R., Gaido K., Cook J., et al. Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod Toxicol 11 (1997) 719-750
3. Laws S.C., Carey S.A., Ferrell J.M., Bodman G.J., and Cooper R.L. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54 (2000) 154-167
4. Bolger R., Wiese T.E., Ervin K., Nestich S., and Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ Health Perspect 106 (1998) 551-557
5. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., and Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103 Suppl 7 (1995) 113-122
6. Hong E.J., Choi K.C., and Jeung E.B. Induction of calbindin-D9k messenger RNA and protein by maternal exposure to alkylphenols during late pregnancy in maternal and neonatal uteri of rats. Biol Reprod 71 (2004) 669-675
7. Arnold S.F., Robinson M.K., Notides A.C., Guillette Jr. L.J., and McLachlan J.A. A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ Health Perspect 104 (1996) 544-548
8. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., and Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105 (1997) 70-76
9. White R., Jobling S., Hoare S.A., Sumpter J.P., and Parker M.G. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135 (1994) 175-182
10. Hong E.J., Choi K.C., and Jeung E.B. Maternal-fetal transfer of endocrine disruptors in the induction of Calbindin-D9k mRNA and protein during pregnancy in rat model. Mol Cell Endocrinol 212 (2003) 63-72
11. Hong E.J., Choi K.C., and Jeung E.B. Maternal exposure to bisphenol a during late pregnancy resulted in an increase of Calbindin-D9k mRNA and protein in maternal and postnatal rat uteri. J Reprod Dev 51 (2005) 499-508
12. Hong E.J., Choi K.C., Jung Y.W., Leung P.C., and Jeung E.B. Transfer of maternally injected endocrine disruptors through breast milk during lactation induces neonatal Calbindin-D9k in the rat model. Reprod Toxicol 18 (2004) 661-668
13. Newbold R.R., Jefferson W.N., Padilla-Banks E., and Haseman J. Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects. Reprod Toxicol 18 (2004) 399-406
14. Newbold R.R. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 199 (2004) 142-150
15. Swan S.H. Intrauterine exposure to diethylstilbestrol: long-term effects in humans. Apmis 108 (2000) 793-804
16. Bibbo M., Gill W.B., Azizi F., Blough R., Fang V.S., Rosenfield R.L., et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 49 (1977) 1-8
17. Gill W.B., Schumacher G.F., Bibbo M., Straus II F.H., and Schoenberg H.W. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 122 (1979) 36-39
18. Wilcox A.J., Baird D.D., Weinberg C.R., Hornsby P.P., and Herbst A.L. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 332 (1995) 1411-1416
19. McLachlan J.A., Newbold R.R., and Bullock B.C. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40 (1980) 3988-3999
20. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 103 Suppl 7 (1995) 83-87
21. Crisp T.M., Clegg E.D., Cooper R.L., Wood W.P., Anderson D.G., Baetcke K.P., et al. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 106 Suppl 1 (1998) 11-56
22. Huang W.W., Yin Y., Bi Q., Chiang T.C., Garner N., Vuoristo J., et al. Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol 19 (2005) 669-682
23. Miller S., Kennedy D., Thomson J., Han F., Smith R., Ing N., et al. A rapid and sensitive reporter gene that uses green fluorescent protein expression to detect chemicals with estrogenic activity. Toxicol Sci 55 (2000) 69-77
24. Seifert M.F., Gray R.W., and Bruns M.E. Elevated levels of vitamin D-dependent calcium-binding protein (calbindin-D9k) in the osteosclerotic (oc) mouse. Endocrinology 122 (1988) 1067-1073
25. Balaguer P., Francois F., Comunale F., Fenet H., Boussioux A.M., Pons M., et al. Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci Total Environ 233 (1999) 47-56
26. Ren L., Marquardt M.A., and Lech J.J. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem Biol Interact 104 (1997) 55-64
27. Heppell S.A., Denslow N.D., Folmar L.C., and Sullivan C.V. Universal assay of vitellogenin as a biomarker for environmental estrogens. Environ Health Perspect 103 Suppl 7 (1995) 9-15
28. Francois E., Wang D.Y., Fulthorpe R., Liss S.N., and Edwards E.A. DNA microarrays for detecting endocrine-disrupting compounds. Biotechnol Adv 22 (2003) 17-26
29. Hewitt S.C., Deroo B.J., Hansen K., Collins J., Grissom S., Afshari C.A., et al. Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol 17 (2003) 2070-2083
30. Naciff J.M., Overmann G.J., Torontali S.M., Carr G.J., Tiesman J.P., Richardson B.D., et al. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 72 (2003) 314-330
31. Moggs J.G., Ashby J., Tinwell H., Lim F.L., Moore D.J., Kimber I., et al. The need to decide if all estrogens are intrinsically similar. Environ Health Perspect 112 (2004) 1137-1142
32. Ise R., Han D., Takahashi Y., Terasaka S., Inoue A., Tanji M., et al. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 579 (2005) 1732-1740
33. Naciff J.M., Jump M.L., Torontali S.M., Carr G.J., Tiesman J.P., Overmann G.J., et al. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68 (2002) 184-199
34. Watanabe H., Suzuki A., Kobayashi M., Takahashi E., Itamoto M., Lubahn D.B., et al. Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J Mol Endocrinol 30 (2003) 347-358
35. Hasty L.A., and Lyttle C.R. Progesterone and RU486 regulation of uterine complement C3 after prior induction with estradiol. Biol Reprod 47 (1992) 285-290
36. Jefferson W.N., Padilla-Banks E., and Newbold R.R. Lactoferrin is an estrogen responsive protein in the uterus of mice and rats. Reprod Toxicol 14 (2000) 103-110
37. Sundstrom S.A., Komm B.S., Ponce-de-Leon H., Yi Z., Teuscher C., and Lyttle C.R. Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem 264 (1989) 16941-16947
38. Bigsby R.M., and Young P.C. Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus. Am J Obstet Gynecol 171 (1994) 188-194
39. Brown E.O., Sundstrom S.A., Komm B.S., Yi Z., Teuscher C., and Lyttle C.R. Progesterone regulation of estradiol-induced rat uterine secretory protein, complement C3. Biol Reprod 42 (1990) 713-719
40. Hopert A.C., Beyer A., Frank K., Strunck E., Wunsche W., and Vollmer G. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model. Environ Health Perspect 106 (1998) 581-586
41. Howe R.S., Lee Y.H., Fischkoff S.A., Teuscher C., and Lyttle C.R. Glucocorticoid and progestin regulation of eosinophil chemotactic factor and complement C3 in the estrogen-treated rat uterus. Endocrinology 126 (1990) 3193-3199
42. Leiva M.C., Lyttle C.R., and Jellinck P.H. Complement C3 synthesis, peroxidase activity and eosinophil chemotaxis in the rat uterus: effect of estradiol and testosterone. Mol Cell Endocrinol 81 (1991) 105-111
43. Strunck E., Stemmann N., Hopert A., Wunsche W., Frank K., and Vollmer G. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 74 (2000) 73-81
44. Nephew K.P., Tang M., and Khan S.A. Estrogen differentially affects c-jun expression in uterine tissue compartments. Endocrinology 134 (1994) 1827-1834
45. Nephew K.P., Peters G.A., and Khan S.A. Cellular localization of estradiol-induced c-fos messenger ribonucleic acid in the rat uterus: c-fos expression and uterine cell proliferation do not correlate strictly. Endocrinology 136 (1995) 3007-3015
46. Angel P., and Karin M. The role of Jun. Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072 (1991) 129-157
47. Moggs J.G. Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology 213 (2005) 177-193
48. Watanabe H., Suzuki A., Mizutani T., Khono S., Lubahn D.B., Handa H., et al. Genome-wide analysis of changes in early gene expression induced by oestrogen. Genes Cells 7 (2002) 497-507
49. Liang G., and Hai T. Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein. J Biol Chem 272 (1997) 24088-24095
50. Goodrich J.A., Cutler G., and Tjian R. Contacts in context: promoter specificity and macromolecular interactions in transcription. Cell 84 (1996) 825-830
51. Bardin A., Boulle N., Lazennec G., Vignon F., and Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11 (2004) 537-551
52. Dhar D.K., Wang T.C., Maruyama R., Udagawa J., Kubota H., Fuji T., et al. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 83 (2003) 1343-1352
53. Charpentier A.H., Bednarek A.K., Daniel R.L., Hawkins K.A., Laflin K.J., Gaddis S., et al. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60 (2000) 5977-5983
54. Byrne J.A., Mattei M.G., and Basset P. Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52). Genomics 35 (1996) 523-532
55. Tsai R.Y., and McKay R.D. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 16 (2002) 2991-3003
56. Yang H.X., Jin G.L., Meng L., Zhang J.Z., Liu W.B., and Shou C.C. Screening and identification of proteins interacting with nucleostemin. World J Gastroenterol 11 (2005) 4812-4814
57. Wang X., Jones T.D., Maclennan G.T., Yang X.J., Lopez-Beltran A., Eble J.N., et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25 (2005) 2001-2004
58. Wenger C.R., Beardslee S., Owens M.A., Pounds G., Oldaker T., Vendely P., et al. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28 (1993) 9-20
59. Jensen V., Ladekarl M., Holm-Nielsen P., Melsen F., and Soerensen F.B. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol 176 (1995) 343-352